References
- Lamble Collected Reviews J. W. Towards Understanding Receptors, Current Reviews in Biomedicine. Elsevier Biomedical Press, Amsterdam 1981
- Nahorski S. R. Identification and significance of beta adrenoceptor subtypes. Trends Pharmacol. Sci. 1981; 2: 18–20
- Seeman P. Brain dopamine receptors. Pharmacol. Rev. 1980; 32: 229–313
- Hoffman B. B., DeLean A., Wood C. L., Schocken D. D., Lefkowitz R. J. Alpha-adrenergic receptor subtypes: quantitative assessment by ligand binding. Life Sci. 1979; 24: 1739–1745
- Minneman K. P., Hegstrand L. R., Molinoff P. B. Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes. Mol. Pharmacol. 1979; 16: 34–46
- Leysen J. E., Niemegeers C. F.E., Tollenaere J. P., Laduron P. M. Serotonergic component of neuroleptic receptors. Nature 1978; 272: 168–171
- DeLean A., Stadel J. M., Lefkowitz R. J. A ternary complex model explains the agonist specific binding properties of the adenylate cyclase - coupled beta adrenergic receptor. J. Biol. Chem. 1980; 255: 7108–7117
- Boeynaems J. M., Dumont J. E. Quantitative analysis of the binding of ligands to their receptors. J. Cyclic Nucleotide Res. 1975; 1: 123–142
- Molinoff P. B., Wolfe B. B., Weiland G. A. Quantitative analysis of drug receptor interactions: II determination of the properties of receptor subtypes. Life Sci. 1981; 29: 427–443
- Cheng Y. C., Prusoff W. H. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 1973; 22: 3099–3108
- Bennett J. P. Neurotransmitter Receptor Binding, H. I. Yamamura. Raven Press, New York 1978; 57–90
- Throughout this paper Site 1 is considered to be that site with the higher apparent affinity (IC50(1) IC50(2)), so that R is always greater than unity. A completely analogous but inverse set of relationships is obtained if R is defined as IC50(1) IC50(2)
- Howlett D. R., Nahorski S. R. Quantitative assessment of heterogeneous 3H-spiperone binding to rat neostriatum and frontal cortex. Life Sci. 1980; 26: 511–517
- Dickinson K., Richardson A., Nahorski S. R. Homogeneity of beta-2-adrenoceptors on rat erythrocytes and reticulocytes. Mol. Pharmacol. 1981; 19: 194–204
- Munson P. J., Rodbard D. Ligand: A versatile computerised approach for characterisation of ligand binding systems. Analytical Biochem. 1980; 107: 220–239
- Maguire M. E., Rosse E. M., Gilman A. G. Beta-adrenergic receptor: Ligand binding properties and the interaction with adenylyl cyclase. Ad. Cyclic Nuc. Res. 1977; 8: 1–74
- Jacobs S., Chang K. J., Cuatrecases P. Estimation of hormone receptor affinity by competitive displacement of labelled ligand; effect of concentration of receptor and of labelled ligand. Biochem. Biophys. Res. Comm. 1975; 66: 687–692
- Rugg E. L., Barnett D. B., Nahorski S. R. Coexistence of beta-1 and beta-2-adrenoceptors in mammalian lung: evidence from direct binding studies. Mol. Pharmacol. 1978; 14: 996–1005
- Munson P. J. Experimental artifacts and the analysis of ligand binding data: results of a computer simulation. J. Rec. Res. 1983; 3: 249–259
- Burgisser E. Model testing in radioligand/receptor interaction by Monte Carlosimulation. J. Rec. Res. 1983; 3: 261–281
- Nahorski S. R. Heterogeneity of cerebral beta-adrenoceptor binding sites in various vertebrate species. Eur. J. Pharmacol. 1978; 51: 199–209
- Gillan M. G.C., Kosterlitz H. W. Spectrum of the μ-, δ- and K- binding sites in homogenates of rat brain. Br. J. Pharmacol. 1982; 77: 461–469